Stem Cell-Based Immunomodulation in Type 1 Diabetes: Beyond the Regenerative Approach

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|29|3229-3242

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.29, 2011-10, pp. : 3229-3242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amniotic Fluid Stem Cells: a Promising Therapeutic Resource for Cell-Based Regenerative Therapy

By  

Current Pharmaceutical Design, Vol. 18, Iss. 13, 2012-05 ,pp. : 1846-1863

Bentham Science Publishers

Access to resources Recommend Favorite

The Developing Role of Neuregulin1 In Cardiac Regenerative Stem Cell Therapy

By  

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4906-4910

Bentham Science Publishers

Access to resources Recommend Favorite

Stem Cell-Based Toxicity Screening: Recent Advances in Hepatocyte Generation

By Greenhough Sebastian   Hay David C.  

Pharmaceutical Medicine, Vol. 26, Iss. 2, 2012-04 ,pp. : 85-89

Adis International

Access to resources Recommend Favorite

Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1114-1127

Bentham Science Publishers

Access to resources Recommend Favorite

Preconditioned Stem Cells: A Promising Strategy for Cell-Based Ischemic Stroke Therapy

By  

Current Drug Targets, Vol. 15, Iss. 8, 2014-07 ,pp. : 771-779

Bentham Science Publishers

Access to resources Recommend Favorite